Head and Neck Cancer
Showing NaN - NaN of 92
Head Neck Cancer, Obstructive Sleep Apnea Trial in Nashville (Nerve stimulation using nerve stimulation device and sterile wire
Not yet recruiting
- Head and Neck Cancer
- Obstructive Sleep Apnea
- Nerve stimulation using nerve stimulation device and sterile wire electrode.
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 22, 2023
3D Specimen Maps for RT Planning
Recruiting
- Head and Neck Cancer
- +2 more
-
Nashville, TennesseeVanderbilt Medical Center
Feb 23, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Head Neck Cancer, Obstructive Sleep Apnea Trial in Nashville (Nerve stimulation using nerve stimulation device and sterile wire
Not yet recruiting
- Head and Neck Cancer
- Obstructive Sleep Apnea
- Nerve stimulation using nerve stimulation device and sterile wire electrode.
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 27, 2022
Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)
Active, not recruiting
- Melanoma
- +7 more
- Autogene cevumeran
- Atezolizumab
-
Scottsdale, Arizona
- +36 more
Dec 22, 2022
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)
Recruiting
- Head and Neck Cancer
- biologic sample preservation procedure
- medical chart review
-
Nashville, Tennessee
- +3 more
Oct 28, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022
Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)
Active, not recruiting
- Metastatic Cancer
- +9 more
-
Mobile, Alabama
- +19 more
Aug 1, 2022
Radiation-Induced Xerostomia, Head Neck Cancer, Radiation Toxicity Trial in United States (Standard Oral Hygiene, Standard Oral
Completed
- Radiation-Induced Xerostomia
- +3 more
- Standard Oral Hygiene
- +2 more
-
Burbank, California
- +35 more
Jul 29, 2022
Head Neck Cancer Trial in Nashville (e-learning didactic module, Personal reflection activities)
Recruiting
- Head and Neck Cancer
- e-learning didactic module
- Personal reflection activities
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 5, 2022
Head Neck Cancer Trial in Nashville (IPC-1000, Magnetic resonance imaging, Correlative Studies)
Suspended
- Head and Neck Cancer
- IPC-1000
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 30, 2022
Head Neck Cancer Trial in United States (drug, radiation, procedure)
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,
Active, not recruiting
- Head and Neck Cancer
- cisplatin
- +2 more
-
Birmingham, Alabama
- +267 more
Apr 6, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Head Neck Cancer, Locally Advanced Head and Neck Carcinoma Trial in Nashville (Gabapentin, Ketamine)
Recruiting
- Head and Neck Cancer
- Locally Advanced Head and Neck Carcinoma
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Feb 16, 2022